Centre de connaissances

Auteurs:

International Pharmaceutical Federation

Prestation de services États-Unis Royaume-Uni Afrique du Sud Philippines Australie Argentine

Long-term impact of a "3 + 0" schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002-2014

Auteurs:

Prestation de services Australie Infection à pneumocoque

Control of HPV-associated cancers with HPV vaccination

Auteurs:

Prestation de services Australie Papillomavirus humain

Continuous active surveillance of adverse events following immunisation using SMS technology.

Auteurs:

Prestation de services Australie

Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial

Auteurs:

M. Tashani et al.

Prestation de services Australie Infection à pneumocoque

Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programm

Auteurs:

G. L. Lawrence

Prestation de services Australie Méningite à méningocoques

Using automated text messages to monitor adverse events following immunisation in general practice

Auteurs:

Prestation de services Australie

Parental perspectives of vaccine safety and experience of adverse events following immunisation

Auteurs:

Prestation de services Australie

Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

Auteurs:

Vaccins et dispositifs d'administration Uruguay États-Unis Chili Canada Brésil Australie

HPV vaccine effect: is the glass half full or half empty?

Auteurs:

Prestation de services Australie Papillomavirus humain

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

Auteurs:

Prestation de services Australie Papillomavirus humain

Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study

Auteurs:

Gestion de programme Australie Papillomavirus humain

I Immunise: An evaluation of a values-based campaign to change attitudes and beliefs

Auteurs:

Prestation de services Australie

Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015

Auteurs:

Données Australie Grippe

Media coverage of health issues and how to work more effectively with journalists

Auteurs:

Prestation de services Australie

Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation

Auteurs:

Données Australie Grippe

Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?

Auteurs:

Données Australie Infection à pneumocoque Grippe

Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine

Auteurs:

Prestation de services Australie Infection à pneumocoque

Centre de Connaissances

Home-based record (HBR): Australia-South Australia 2016

Home-based record (HBR): Australia-ACT 2014

An overview of current pharmacy impact on immunisation

Long-term impact of a "3 + 0" schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002-2014

Control of HPV-associated cancers with HPV vaccination

Continuous active surveillance of adverse events following immunisation using SMS technology.

Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial

Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programm

Using automated text messages to monitor adverse events following immunisation in general practice

Parental perspectives of vaccine safety and experience of adverse events following immunisation

Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

HPV vaccine effect: is the glass half full or half empty?

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study

I Immunise: An evaluation of a values-based campaign to change attitudes and beliefs

Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015

Media coverage of health issues and how to work more effectively with journalists

Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation

Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?

Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine

Filtres

À propos

Centre de connaissances

Communauté

Plus